-
FDA’s Sentinel Initiative Project: An Overview, Progress To Date, And Next Steps
Presentation Made At September 17, 2009 FDA Drug Safety Oversight Board Meeting (Posted by Tom Lamb at DrugInjuryWatch.com) At the September 17, 2009 meeting of the FDA Drug Safety Oversight Board (DSB), members heard…
-
A Review Of Recent Research On Issue Of Whether Januvia Can Cause Pancreatitis
Is Pancreatitis A Januvia Side Effect Or Is There An Increased Risk Of This Medical Condition Among Type 2 Diabetics Across All Treatments (Posted by Tom Lamb at DrugInjuryWatch.com) A few weeks back we…
-
Waiting For The Results From Swissmedic Safety Analysis Of Yaz And Other Drospirenone-Containing Contraceptives
Prompted By Investigation Into Death Of Young Woman Who Died While Using Yaz; Results Of Analysis Expected In Late October 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) In late September 2009 we learned that…
-
FDA Transparency Task Force Will Hold Its Second Public Meeting On November 3, 2009
Emerging Safety Issues Concerning FDA-Regulated Products Is One Issue For Discussion Listed in October 2009 Federal Register Notice (Posted by Tom Lamb at DrugInjuryWatch.com) In the Federal Register for October 5, 2009 the FDA…
-
October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court
MDL No. 2100 — IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation — Assigned To Southern District of Illinois (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Our Focus…